Abstract:Caveolin-3 is a muscle-specific protein on the membrane of myocytes correlated with a variety of cardiovascular diseases. It is now clear that the caveolin-3 plays a critical role in the cardiovascular system and a significant role in cardiac protective signaling. Mutations in the gene encoding caveolin-3 cause a broad spectrum of clinical phenotypes, ranging from persistent elevations in the serum levels of creatine kinase in asymptomatic humans to cardiomyopathy. The influence of Caveolin-3(CAV-3) mutations on current density parallels the effect on channel trafficking. For example, mutations in the CAV-3 gene promote ventricular arrhythmogenesis in long QT syndrome 9 by a combined decrease in the loss of the inward rectifier current (IK1) and gain of the late sodium current (INa-L). The functional significance of the caveolin-3 has proved that caveolin-3 overexpression or knockdown contributes to the occurrence and development of arrhythmias. Caveolin-3 overexpression could lead to reduced diastolic spontaneous Ca2+ waves, thus leading to the abnormal L-Type calcium channel current-induced ventricular arrhythmias. Moreover, CAV-3 knockdown resulted in a shift to more negative values in the hyperpolarization-activated cyclic nucleotide channel 4 current (IHCN4) activation curve and a significant decrease in IHCN4 whole-cell current density. Recent evidence indicates that caveolin-3 plays a significant role in adipose tissue and is related to obesity development. The role of caveolin-3 in glucose homeostasis has attracted increasing attention. This review highlights the underlining mechanisms of caveolin-3 in arrhythmia. Progress in this field may contribute to novel therapeutic approaches for patients prone to developing arrhythmia.

Caveolin As a Novel Potential Therapeutic Target in Cardiac and Vascular Diseases: A Mini Review

Caveolin's Biological Function and Its Effect in Diseases

Pathophysiology and Molecular Mechanism of Caveolin Involved in Myocardial Protection Strategies in Ischemic Conditioning.

Caveolin-1 in autophagy: A potential therapeutic target in atherosclerosis

Caveolae: Molecular Insights and Therapeutic Targets for Stroke

The Role of Caveolae in Endothelial Dysfunction.

Physiological and pathological roles of caveolins in the central nervous system

Caveolin-1, a novel player in cognitive decline

Role of Caveolins in the Blood-Brain Barrier Disruption after Cerebral Ischemia

Novel Perspective of Cardiovascular Diseases: Volume-Regulatory Anion Channels in the Cell Membrane

Unraveling the Cave: A Seventy-Year Journey into the Caveolar Network, Cellular Signaling, and Human Disease

The Role of Glycocalyx and Caveolae in Vascular Homeostasis and Diseases

The Recent Advances in the Function and Mechanism of Caveolin-1 in Retinal Neovascularization

Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease

Epigenetic modifications of caveolae associated proteins in health and disease

The critical roles of caveolin-1 in lung diseases

Lessons from cavin-1 deficiency

Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease

Caveolin-3 and Arrhythmias: Insights into the Molecular Mechanisms